SPONSOR
BridGene Biosciences Inc.
Total Trials
1
Recruiting
1
Phases
Phase 1
BridGene Biosciences Inc. is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Mesothelioma, Epithelioid Hemangioendothelioma(EHE), Solid Tumor.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — BridGene Biosciences Inc.
How many clinical trials has BridGene Biosciences Inc. sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by BridGene Biosciences Inc., of which 1 are actively recruiting participants. These trials cover conditions including Mesothelioma, Epithelioid Hemangioendothelioma(EHE), Solid Tumor. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does BridGene Biosciences Inc. research focus on?
BridGene Biosciences Inc. clinical trials span Mesothelioma, Epithelioid Hemangioendothelioma(EHE), Solid Tumor. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a BridGene Biosciences Inc. clinical trial?
To participate in a BridGene Biosciences Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all BridGene Biosciences Inc. trials with current recruitment status updated daily.
Clinical Trials by BridGene Biosciences Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology